doi: 10.1136/jmedgenet-2014-102554. Epub 2014 Aug 28.
Efficient strategy for the molecular diagnosis of intellectual disability using targeted high-throughput sequencing
Claire Redin 1, Bénédicte Gérard 2, Julia Lauer 2, Yvan Herenger 2, Jean Muller 3, Angélique Quartier 1, Alice Masurel-Paulet 4, Marjolaine Willems 5, Gaétan Lesca 6, Salima El-Chehadeh 4, Stéphanie Le Gras 7, Serge Vicaire 7, Muriel Philipps 7, Michaël Dumas 7, Véronique Geoffroy 8, Claire Feger 7, Nicolas Haumesser 1, Yves Alembik 9, Magalie Barth 10, Dominique Bonneau 10, Estelle Colin 10, Hélène Dollfus 11, Bérénice Doray 9, Marie-Ange Delrue 12, Valérie Drouin-Garraud 13, Elisabeth Flori 9, Mélanie Fradin 14, Christine Francannet 15, Alice Goldenberg 13, Serge Lumbroso 16, Michèle Mathieu-Dramard 17, Dominique Martin-Coignard 18, Didier Lacombe 12, Gilles Morin 17, Anne Polge 16, Sylvie Sukno 19, Christel Thauvin-Robinet 4, Julien Thevenon 4, Martine Doco-Fenzy 20, David Genevieve 5, Pierre Sarda 5, Patrick Edery 6, Bertrand Isidor 21, Bernard Jost 7, Laurence Olivier-Faivre 4, Jean-Louis Mandel 22, Amélie Piton 1
Affiliations
- PMID:25167861
- PMCID: PMC4215287
- DOI: 10.1136/jmedgenet-2014-102554
Item in Clipboard
Efficient strategy for the molecular diagnosis of intellectual disability using targeted high-throughput sequencing
Claire Redin et al. J Med Genet.2014 Nov.
Display options
Format
Display options
Format
Abstract
Background: Intellectual disability (ID) is characterised by an extreme genetic heterogeneity. Several hundred genes have been associated to monogenic forms of ID, considerably complicating molecular diagnostics. Trio-exome sequencing was recently proposed as a diagnostic approach, yet remains costly for a general implementation.
Methods: We report the alternative strategy of targeted high-throughput sequencing of 217 genes in which mutations had been reported in patients with ID or autism as the major clinical concern. We analysed 106 patients with ID of unknown aetiology following array-CGH analysis and other genetic investigations. Ninety per cent of these patients were males, and 75% sporadic cases.
Results: We identified 26 causative mutations: 16 in X-linked genes (ATRX, CUL4B, DMD, FMR1, HCFC1, IL1RAPL1, IQSEC2, KDM5C, MAOA, MECP2, SLC9A6, SLC16A2, PHF8) and 10 de novo in autosomal-dominant genes (DYRK1A, GRIN1, MED13L, TCF4, RAI1, SHANK3, SLC2A1, SYNGAP1). We also detected four possibly causative mutations (eg, in NLGN3) requiring further investigations. We present detailed reasoning for assigning causality for each mutation, and associated patients' clinical information. Some genes were hit more than once in our cohort, suggesting they correspond to more frequent ID-associated conditions (KDM5C, MECP2, DYRK1A, TCF4). We highlight some unexpected genotype to phenotype correlations, with causative mutations being identified in genes associated to defined syndromes in patients deviating from the classic phenotype (DMD, TCF4, MECP2). We also bring additional supportive (HCFC1, MED13L) or unsupportive (SHROOM4, SRPX2) evidences for the implication of previous candidate genes or mutations in cognitive disorders.
Conclusions: With a diagnostic yield of 25% targeted sequencing appears relevant as a first intention test for the diagnosis of ID, but importantly will also contribute to a better understanding regarding the specific contribution of the many genes implicated in ID and autism.
Keywords: autism; causative; high-throughput sequencing; intellectual disability; mutation.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Figures
Inherited disrupting splice variant inDEAF1: what contribution to the phenotype?(A) Pedigree showing the maternally inherited splice variant inDEAF1 (c.290-3C>G); (B) prediction scores for the effect of the herein described variant on splicing (prediction scores for acceptor splice sites (ASS) as computed by SpliceSite Finder, MaxEntScan, NNsplice, GeneSplicer and Human Splicing Finder for the consensus ASS with either the wild-type or the mutated allele); (C) localisation of the variant, and its resulting effect on splicing in vitro (minigene construct): 90% of abnormal transcripts: 80% with entire exon #2 skipped, and 10% using the alternative ASS c.290-16 both leading to a frameshift and a premature stop codon.
Truncating variants not or ambiguously co-segregating with ID. (A) Pedigree of patient APN-13 carrying a frameshift variant inSRPX2 (c.602del, p.Ala201Valfs*10) demonstrating the likely inheritance from the asymptomatic (deceased) maternal grandfather, yet a putative germinal mosaicism of a de novo mutation cannot be excluded.; (B) predicted functional domains of SRXP2 from Pfam indicating locations of the herein identified mutation (in red) and those previously described. DUF4174: domain of unknown function; (C) pedigree showing the non-segregating nonsense variant inSHROOM4 (c.3772C>T; p.Gln1258*) in the family of patient APN-86; (D) location of the premature stop codon, which would disrupt the ASD2 domain of the protein.
Patient carrying two probably damaging missense variants inHCFC1 andATRX: one causative mutation and one modifier variant? (A) Family tree of patient APN-113: proband carries a missense mutation inHCFC1 (c.218C>T; p.Ala73Val) already reported in two patients withcblX as well as another missense variant inATRX (c.1013C>G, p.Ser338Cys). Both variants are maternally inherited, absent from the unaffected brother, but carried by the younger brother who died of sudden death at 2 months old; (B) associated predictions for the recurrent pathogenic missense mutation inHCFC1 and the possible modifier inATRX, showing putative pathogenicity and moderate nucleotide conservation; (C) representation of HCFC1 and its domains: kelch domains (K1–K5), Fn3 (fibronectin type 3), basic domain, HCF-proteolysis repeats (HCF-pro), acidic domain and nuclear localisation signal (NLS) domain. The initial mutations involved in milder non-syndromic ID are indicated above: a regulatory variant in the 5′UTR ofHCFC1 was identified by targeted massive parallel resequencing in a family with probable X-linked ID (XLID) (MRX3), which had for long remained unsolved. This variant was disrupting the functional binding site of the transcription factor YY1 within theHCFC1 promoter region, leading to an upregulation of its expression in lymphoblastoid cells. Subsequent screening of additional unsolved families identified one single co-segregating missense variant (c.674G>A; p.Ser225Asn) inHCFC1. The phenotype of both patients was rather mild: non-syndromic mild to moderate ID. In the bottom are indicated the mutations recently described incblX patients; (D) theATRX missense variant is located close but outside of the hotspot for disease-causing missense mutations (in the zinc-finger binding domain, in green) reported in patients withATRX mutations, in red: mutations reported independently in at least two patients. Mutations are indicated when affecting residues 1–700 (reported in OMIM, ClinVar or in75), the rest of the protein is not represented; (E) Clinical information regarding APN-113 and previous genetic explorations, including X-inactivation status in the mother.CblX patients present with the same very severe phenotype: severe ID, early infantile epilepsy, choreoathetosis, microcephaly and more variable muscular hypotonia. Three of them are reported with early death in infancy; (F) biochemical abnormalities observed in the two affected brothers are similar to those previously observed.
Similar articles
- Targeted Next-Generation Sequencing in Patients with Suggestive X-Linked Intellectual Disability.Ibarluzea N, Hoz AB, Villate O, Llano I, Ocio I, Martí I, Guitart M, Gabau E, Andrade F, Gener B, Tejada MI.Ibarluzea N, et al.Genes (Basel). 2020 Jan 2;11(1):51. doi: 10.3390/genes11010051.Genes (Basel). 2020.PMID:31906484Free PMC article.
- Disease-causing variants in TCF4 are a frequent cause of intellectual disability: lessons from large-scale sequencing approaches in diagnosis.Mary L, Piton A, Schaefer E, Mattioli F, Nourisson E, Feger C, Redin C, Barth M, El Chehadeh S, Colin E, Coubes C, Faivre L, Flori E, Geneviève D, Capri Y, Perrin L, Fabre-Teste J, Timbolschi D, Verloes A, Olaso R, Boland A, Deleuze JF, Mandel JL, Gerard B, Giurgea I.Mary L, et al.Eur J Hum Genet. 2018 Jul;26(7):996-1006. doi: 10.1038/s41431-018-0096-4. Epub 2018 Apr 26.Eur J Hum Genet. 2018.PMID:29695756Free PMC article.
- Targeted next generation sequencing in 112 Chinese patients with intellectual disability/developmental delay: novel mutations and candidate gene.Yan H, Shi Z, Wu Y, Xiao J, Gu Q, Yang Y, Li M, Gao K, Chen Y, Yang X, Ji H, Cao B, Duan R, Jiang Y, Wang J.Yan H, et al.BMC Med Genet. 2019 May 14;20(1):80. doi: 10.1186/s12881-019-0794-y.BMC Med Genet. 2019.PMID:31088393Free PMC article.
- KDM5C mutational screening among males with intellectual disability suggestive of X-Linked inheritance and review of the literature.Gonçalves TF, Gonçalves AP, Fintelman Rodrigues N, dos Santos JM, Pimentel MM, Santos-Rebouças CB.Gonçalves TF, et al.Eur J Med Genet. 2014 Mar;57(4):138-44. doi: 10.1016/j.ejmg.2014.02.011. Epub 2014 Feb 27.Eur J Med Genet. 2014.PMID:24583395Review.
- Validation of clinical exome sequencing in the diagnostic procedure of patients with intellectual disability in clinical practice.Ballesta-Martínez MJ, Pérez-Fernández V, López-González V, Sánchez-Soler MJ, Serrano-Antón AT, Rodríguez-Peña LI, Barreda-Sánchez M, Armengol-Dulcet L, Guillén-Navarro E.Ballesta-Martínez MJ, et al.Orphanet J Rare Dis. 2023 Jul 21;18(1):201. doi: 10.1186/s13023-023-02809-z.Orphanet J Rare Dis. 2023.PMID:37480025Free PMC article.Review.
Cited by
- Novel Variations in theKDM5C Gene Causing X-Linked Intellectual Disability.Wu PM, Yu WH, Chiang CW, Wu CY, Chen JS, Tu YF.Wu PM, et al.Neurol Genet. 2021 Dec 3;8(1):e646. doi: 10.1212/NXG.0000000000000646. eCollection 2022 Feb.Neurol Genet. 2021.PMID:34877407Free PMC article.
- Complex Diagnostics of Non-Specific Intellectual Developmental Disorder.Levchenko O, Dadali E, Bessonova L, Demina N, Rudenskaya G, Matyushchenko G, Markova T, Anisimova I, Semenova N, Shchagina O, Ryzhkova O, Zinchenko R, Galkina V, Voinova V, Nagieva S, Lavrov A.Levchenko O, et al.Int J Mol Sci. 2022 Jul 14;23(14):7764. doi: 10.3390/ijms23147764.Int J Mol Sci. 2022.PMID:35887114Free PMC article.
- Diagnosis of intellectual disability/global developmental delay via genetic analysis in a central region of China.Liao LH, Chen C, Peng J, Wu LW, He F, Yang LF, Zhang CL, Wang GL, Peng P, Ma YP, Miao P, Yin F.Liao LH, et al.Chin Med J (Engl). 2019 Jul 5;132(13):1533-1540. doi: 10.1097/CM9.0000000000000295.Chin Med J (Engl). 2019.PMID:31205075Free PMC article.
- Replicate exome-sequencing in a multiple-generation family: improved interpretation of next-generation sequencing data.Cherukuri PF, Maduro V, Fuentes-Fajardo KV, Lam K; NISC Comparative Sequencing Program; Adams DR, Tifft CJ, Mullikin JC, Gahl WA, Boerkoel CF.Cherukuri PF, et al.BMC Genomics. 2015 Nov 25;16:998. doi: 10.1186/s12864-015-2107-y.BMC Genomics. 2015.PMID:26602380Free PMC article.
- Systematic Phenomics Analysis Deconvolutes Genes Mutated in Intellectual Disability into Biologically Coherent Modules.Kochinke K, Zweier C, Nijhof B, Fenckova M, Cizek P, Honti F, Keerthikumar S, Oortveld MA, Kleefstra T, Kramer JM, Webber C, Huynen MA, Schenck A.Kochinke K, et al.Am J Hum Genet. 2016 Jan 7;98(1):149-64. doi: 10.1016/j.ajhg.2015.11.024.Am J Hum Genet. 2016.PMID:26748517Free PMC article.
References
- Leonard H, Wen X. The epidemiology of mental retardation: challenges and opportunities in the new millennium. Ment Retard Dev Disabil Res Rev 2002;8:117–34. - PubMed
- Maulik PK, Mascarenhas MN, Mathers CD, Dua T, Saxena S. Prevalence of intellectual disability: a meta-analysis of population-based studies. Res Dev Disabil 2011;32:419–36. - PubMed
- de Ligt J, Willemsen MH, van Bon BW, Kleefstra T, Yntema HG, Kroes T, Vulto-van Silfhout AT, Koolen DA, de Vries P, Gilissen C, del Rosario M, Hoischen A, Scheffer H, de Vries BB, Brunner HG, Veltman JA, Vissers LE. Diagnostic exome sequencing in persons with severe intellectual disability. N Engl J Med 2012;367:1921–9. - PubMed
- Najmabadi H, Hu H, Garshasbi M, Zemojtel T, Abedini SS, Chen W, Hosseini M, Behjati F, Haas S, Jamali P, Zecha A, Mohseni M, Puttmann L, Vahid LN, Jensen C, Moheb LA, Bienek M, Larti F, Mueller I, Weissmann R, Darvish H, Wrogemann K, Hadavi V, Lipkowitz B, Esmaeeli-Nieh S, Wieczorek D, Kariminejad R, Firouzabadi SG, Cohen M, Fattahi Z, Rost I, Mojahedi F, Hertzberg C, Dehghan A, Rajab A, Banavandi MJ, Hoffer J, Falah M, Musante L, Kalscheuer V, Ullmann R, Kuss AW, Tzschach A, Kahrizi K, Ropers HH. Deep sequencing reveals 50 novel genes for recessive cognitive disorders. Nature 2011;478:57–63. - PubMed
Publication types
MeSH terms
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous